{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:42:10Z","timestamp":1791175330028,"version":"4.1.0"},"reference-count":46,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:p>Somatostatin receptor (SS\u2010R) scintigraphy successfully\u00a0 shows primary cancers and metastases in patients with a variety of SS\u2010R\u2010positive tumours. <jats:italic>In vitro<\/jats:italic> studies have shown that SS\u2010Rs are present in lymph nodes from patients with Hodgkin's disease (HD). We performed a prospective study in 126 newly diagnosed patients with HD and compared the results of SS\u2010R scintigraphy with conventional staging procedures, i.e. physical examination, computerized tomography (CT) scanning and other imaging techniques. We report positive scintigraphy in all patients. The lesion\u2010related sensitivity was 94% and varied from 98%\u00a0for supradiaphragmatic lesions to 67% for infradiaphragmatic lesions. In comparison with CT scanning and ultrasonography, SS\u2010R scintigraphy provided superior results for the detection of Hodgkin's localizations above the diaphragm. In the intra\u2010abdominal region, the CT scan was more sensitive than the SS\u2010R scan. A false\u2010positive scan was rarely seen. In stages I and II supradiaphragmatic HD patients, SS\u2010R scintigraphy detected more advanced disease in 18% (15 out of 83) of patients, resulting in an upstaging to stage III or IV, thus directly influencing patient management. Our data would support the validity of SS\u2010R scanning as a powerful imaging technique for the staging of patients with HD.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02583.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:32:45Z","timestamp":1047364365000},"page":"936-944","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Somatostatin receptor scintigraphy useful in stage I\u2013II Hodgkin's disease: more extended disease identified"],"prefix":"10.1111","volume":"112","author":[{"given":"P. J.","family":"Lugtenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. P.","family":"Krenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Valkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Y.","family":"Oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. W. J.","family":"Lamberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J. C.","family":"Eijkemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. L. J.","family":"Van Putten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"L\u00f6wenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"270","article-title":"Treatment of early\u2010stage Hodgkin's disease","volume":"36","author":"Advani R.H.","year":"1999","journal-title":"Semininars in Hematology"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008486928190"},{"key":"e_1_2_6_4_1","first-page":"56","article-title":"Somatostatin receptor scintigraphy in malignant lymphoma:\u00a0first results and comparison with glucose metabolism measured by positron\u2010emission tomography","volume":"27","author":"Bares R.","year":"1993","journal-title":"Hormone and Metabolic Research Supplement"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/snuc.2000.7439"},{"key":"e_1_2_6_6_1","first-page":"46","article-title":"Clinical experience with somatostatin receptor imaging in lymphoma","volume":"21","author":"Bong S.B.","year":"1994","journal-title":"Seminars in Oncology Supplement"},{"key":"e_1_2_6_7_1","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone P.P.","year":"1971","journal-title":"Cancer Research"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.6.1092"},{"key":"e_1_2_6_9_1","first-page":"282","article-title":"Treatment of advanced Hodgkin's lymphoma: standard and experimental approaches","volume":"36","author":"Engert A.","year":"1999","journal-title":"Seminars in Hematology"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.175.2.2183289"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.182.2.1732950"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-2998(95)80015-8"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)90780-L"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900301)65:5<1090::AID-CNCR2820650509>3.0.CO;2-#"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-66-790-859"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/10428199709109164","article-title":"Somatostatin receptor scintigraphy in the staging of lymphomas","volume":"26","author":"Ivancevic V.","year":"1997","journal-title":"Leukemia and Lymphoma"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood.V94.2.429","article-title":"Whole\u2010body positron emission tomography using 18F\u2010fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non\u2010Hodgkin's lymphoma had higher diagnostic and prognostic value than classical computed tomography scan imaging","volume":"94","author":"Jerusalem G.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_18_1","first-page":"652","article-title":"Somatostatin receptor scintigraphy with Indium\u2010111\u2010DTPA\u2010Phe\u20101\u2010octreotide in man: metabolism, dosimetry and comparison with Iodine\u2010123\u2010Tyr\u20103\u2010octreotide","volume":"33","author":"Krenning E.P.","year":"1992","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00181765"},{"key":"e_1_2_6_20_1","first-page":"6","article-title":"Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide","volume":"21","author":"Krenning E.P.","year":"1994","journal-title":"Seminars in Oncology Supplement"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/annonc\/10.suppl_2.S23","article-title":"Radiolabelled somatostatin analogue (s) for peptide receptor scintigraphy and radionuclide therapy","volume":"10","author":"Krenning E.P.","year":"1999","journal-title":"Annals of Oncology Supplement"},{"key":"e_1_2_6_22_1","first-page":"1","volume-title":"Nuclear Medicine Annual","author":"Krenning E.P.","year":"1995"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1994.tb04417.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.1.81"},{"key":"e_1_2_6_25_1","first-page":"13","article-title":"Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy","volume":"36","author":"Lipp R.W.","year":"1995","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1630"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.2.318.318"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.2.257"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951015)76:8<1460::AID-CNCR2820760825>3.0.CO;2-Y"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050476"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.1088"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/80.18.1466"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198312153092406"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198312223092506"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910500613"},{"key":"e_1_2_6_36_1","first-page":"77","volume-title":"Clinical Haematology: the Lymphomas","author":"Reznec R.H.","year":"1987"},{"key":"e_1_2_6_37_1","first-page":"43","volume-title":"Clinical SPECT Imaging","author":"Rusinek H.","year":"1995"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.518"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00800590"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050275"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(84)90004-X"},{"key":"e_1_2_6_42_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/blood.V73.1.47.47","article-title":"Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964\u201387","volume":"73","author":"Tubiana M.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.443986.x"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb04634.x"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1989.tb01223.x"},{"key":"e_1_2_6_46_1","first-page":"604","article-title":"Diagnostic role of gallium scanning in the management of lymphoma with mediastinal involvement","volume":"84","author":"Zinzani P.L.","year":"1999","journal-title":"Haematologica"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008327127033"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02583.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02583.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02583.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T16:06:17Z","timestamp":1695830777000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02583.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02583.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02583.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}